XORTX Therapeutics Announces Chairman Anthony Giovinazzos Resignation from Board

On July 31, 2026, XORTX Therapeutics Inc. (NASDAQ: XRTX, TSXV: XRTX, Frankfurt: ANU) announced that Anthony Giovinazzo, ...

Read story →

Vivoryon Therapeutics Reports Q1 2026 Loss, Highlights Kidney-Disease Data and Funding Needs

When the next wave of kidney‑disease treatments is on the horizon, Vivoryon Therapeutics’ Q1 results paint a clear p...

Read story →